News
Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
22h
MedPage Today on MSNCVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers' BankruptcyPeople prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...
4h
Zacks.com on MSNLilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results